U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 181 - 190 of 2063 results

Status:
Investigational
Source:
USAN:Aceburic Acid
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Aceburic acid is the acetyl ester of gamma-hydroxybutyrate (GHB), it has analgesic effects as a prodrug to GHB. GHB is used medically as an anesthetic as well as a treatment for several neurologically affecting diseases.
Status:
Investigational
Source:
INN:broxitalamic acid [INN]
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Broxitalamic acid is tribromobenzoic acid derivative used as x-ray contrast medium
Status:
Investigational
Source:
INN:enfenamic acid
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Enfenamic acid (under brand name tromaril) is an anthranilic acid derivative with potent anti-inflammatory, anti-arthritic, analgesic and antipyretic actions. It has additional unique property of anti-platelet aggregation activity, without disturbing any other blood coagulation factors. It also differs from other non-steroidal anti-inflammatory agents like indomethacin, in producing diuresis and natriuresis. In the clinical study, tromaril showed itself as a strong and effective drug for use in various eye diseases.
Status:
Investigational
Source:
INN:cicrotoic acid [INN]
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Cicrotoic acid is a biochemical drug that acts on bile flow and liquid composition of human bile.
Status:
Investigational
Source:
INN:ioprocemic acid
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Ioprocemic Acid is hydrocinnamic acid derivative patented by Schering-Kahlbaum A.-G. as radiographic contrast medium for liver imaging
Status:
Investigational
Source:
INN:tauroselcholic acid [INN]
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)

Status:
Investigational
Source:
NCT00514501: Phase 2 Interventional Completed Acute Coronary Syndrome
(2007)
Source URL:

Class (Stereo):
CHEMICAL (RACEMIC)

Iodofiltic Acid I-123 is a single-photon branching free fatty acid radiopharmaceutical with potential application in single-photon emission computed tomography (SPECT). Assessment of fatty acid metabolism by radionuclide techniques has a potential role for the early detection of myocardial ischaemia and the assessment of the severity of ischaemic heart disease. The Iodofiltic Acid I-123 scan is preferable because it can provide suitable information for risk stratification just after an acute myocardial infarction (AMI) without requiring the patient to exercise; it can also detect previous ischaemic insult even after recovery of myocardial perfusion, the so- called "ischaemic memory".
Status:
Investigational
Source:
INN:iosumetic acid
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Iosumetic Acid is a triiodoaminoisophthalic acid derivative patented by Schering A.-G. as contrast medium for direct and indirect lymphography.
Status:
Investigational
Source:
INN:iotrizoic acid
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Iotrizoic Acid is acylated amino acid derivative patented by Swiss pharmaceutical company Cilag-Chemie A.-G. as x-ray contrasting agent
Status:
Investigational
Source:
NCT00533377: Phase 2 Interventional Completed Tibial Fractures
(2008)
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)


Evatanepag (CP-533,536) is a prostaglandin E2 EP2 receptor agonist. It stimulates new bone formation on trabecular, endocortical, and periosteal surfaces and enhances fracture healing. Evatanepag was under development with Pfizer as a bone formation stimulant for therapeutic use in the healing of fractures.